Allison W. Kurian, M.D., M.Sc.

Publication Details

  • Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.

    Kurian AW, Sigal BM, Plevritis SK. J Clin Oncol. 2010; 28 (2): 222-31

    Women with BRCA1/2 mutations inherit high risks of breast and ovarian cancer; options to reduce cancer mortality include prophylactic surgery or breast screening, but their efficacy has never been empirically compared. We used decision analysis to simulate risk-reducing strategies in BRCA1/2 mutation carriers and to compare resulting survival probability and causes of death.

    PubMedID: 19996031

Stanford Medicine Resources:

Footer Links: